From Fentanyl Crisis to Genetic Information Rules: A Roundup of Health Headlines
This article provides a summary of recent health news, covering topics like U.S.-China trade tensions over fentanyl, opposition to Roche's acquisition of Catalent, CDC vaccination updates, upcoming bird flu tests, and Eli Lilly's Alzheimer's drug. It also addresses UN discussions on genetic data rules and trends in glaucoma treatment.
Democratic Senator Tammy Baldwin has called on the U.S. Trade Representative to probe China's alleged involvement in the fentanyl crisis, following a petition asking for significant tariffs on Chinese goods.
In the pharmaceutical sector, Roche has voiced concerns over a potential takeover of Catalent that could affect competition within the weight-loss drug market.
The CDC advisors have recommended expanding pneumococcal vaccines to adults aged 50-64, and Quest Diagnostics prepares to launch a bird flu test at October's end.
ALSO READ
-
AI vs Journalism: The Battle for Fair Use
-
FDA Pushes for Testosterone Therapies for Women: Breaking Down Barriers
-
Pennsylvania's Measles Outbreak Sparks CDC Standoff Amid Rising Vaccine Concerns
-
Pennsylvania's Measles Crisis: A Public Health Standoff
-
Pennsylvania’s Measles Outbreak Spurs Clash with Federal Authorities
Google News